New York: In late March, 72-year-old Laura Gross recovered from gallbladder surgery at her home in Fort Lee, New Jersey, when she fell ill again.
Her throat, head and eyes were injured, her muscles and joints were sore, it felt like she was in a fog. Her diagnosis is COVID-19. Four months later, these symptoms still exist.
Gross sees a primary care doctor and specialists including a cardiologist, pulmonologist, endocrinologist, neurologist, and gastroenterologist. “I ve had a headache since April. I ve never stopped running a low-grade temperature,” she said.
Research on COVID-19 patients continues to discover new complications related to the disease.
With increasing evidence that some COVID-19 survivors face debilitating complications for months or even years, healthcare professionals are beginning to study possible long-term costs.
Bruce Lee of the School of Public Health of the City University of New York (CUNY) estimates that if 20% of the U.S. population is infected with the virus, the cost of a year’s post-hospitalization will reach at least $50 billion before long-term treatment is considered. Take care of lingering health problems. Without a vaccine, if 80% of the population were infected, it would cost up to 204 billion US dollars.
Some countries hit hard by the new coronavirus – including the United States, Britain and Italy – are considering whether these long-term effects can be considered a “post-COVID syndrome,” according to Reuters interviews with about a dozen doctors and health economists.
Some hospitals in the United States and Italy have established centers that provide care for these patients and are standardizing follow-up measures.
Both the UK Department of Health and the US Centers for Disease Control and Prevention are leading national studies on the long-term effects of COVID-19. An international team of doctors will advise the World Health Organization (WHO) on the medium and long-term care standards for recovered patients in August.